Developing Adnectins That Target SRC Co-Activator Binding to PXR: A Structural Approach toward Understanding Promiscuity of PXR
Authors:
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 427 (4) , 924-942
Abstract
No abstract availableKeywords
Funding Information
- University of Chicago
This publication has 63 references indexed in Scilit:
- Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspectiveDrug Metabolism Reviews, 2012
- Identification of Clinically Used Drugs That Activate Pregnane X ReceptorsDrug Metabolism and Disposition, 2011
- The role of nuclear receptors in pharmacokinetic drug–drug interactions in oncologyCancer Treatment Reviews, 2007
- Genomic Analysis of the Nuclear Receptor Family: New Insights Into Structure, Regulation, and Evolution From the Rat GenomeGenome Research, 2004
- The Nuclear Pregnane X Receptor Regulates Xenobiotic DetoxificationThe Journal of Nutrition, 2003
- The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic MetabolismEndocrine Reviews, 2002
- Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A inductionProceedings of the National Academy of Sciences, 1998
- The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.Journal of Clinical Investigation, 1998
- The nuclear receptor superfamily: The second decadeCell, 1995
- Steroid hormone receptors: Many Actors in search of a plotCell, 1995